BioXcel Therapeutics (BTAI) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-8.09
-5.46
-2.84
-0.21

Details

Expected EPS
-8.088685
Actual EPS
-5.12
Surprise EPS
2.97
Surprise Percent
+36.7%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -5.12 per share for Q4 2024.

0 Comments

Share your thoughts